Heartbeam Inc (BEAT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Heartbeam Inc (BEAT) has a cash flow conversion efficiency ratio of -5.685x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.61 Million) by net assets ($635.00K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Heartbeam Inc market cap and net worth for the company's overall valuation and market capitalisation.
Heartbeam Inc - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Heartbeam Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Heartbeam Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Heartbeam Inc ranked by their cash flow conversion efficiency. Explore BEAT cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
The Century Co., Ltd.
KO:002420
|
0.002x |
|
Cogra 48 Société Anonyme
PA:ALCOG
|
0.140x |
|
Altech Chemicals Ltd
F:A3Y
|
N/A |
|
TVI Pacific Inc
V:TVI
|
-0.001x |
|
Microba Life Sciences Ltd
AU:MAP
|
-0.184x |
|
Egeplast Ege Plastik Ticaret ve Sanayi AS
IS:EPLAS
|
-0.008x |
|
Grande Group Limited Class A Ordinary Shares
NASDAQ:GRAN
|
0.028x |
|
KPX Lifescience.Co.Ltd
KQ:114450
|
0.095x |
Annual Cash Flow Conversion Efficiency for Heartbeam Inc (2006–2025)
The table below shows the annual cash flow conversion efficiency of Heartbeam Inc from 2006 to 2025. View BEAT live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $2.60 Million | $-13.99 Million | -5.374x | +38.58% |
| 2024-12-31 | $1.65 Million | $-14.47 Million | -8.749x | -1053.02% |
| 2023-12-31 | $15.94 Million | $-12.09 Million | -0.759x | +81.89% |
| 2022-12-31 | $2.37 Million | $-9.95 Million | -4.190x | -1639.73% |
| 2021-12-31 | $13.41 Million | $-3.23 Million | -0.241x | -292.09% |
| 2020-12-31 | $-4.79 Million | $-600.00K | 0.125x | +114.37% |
| 2019-12-31 | $-3.73 Million | $-218.00K | 0.058x | -75.04% |
| 2018-12-31 | $310.49 Million | $72.75 Million | 0.234x | +146.00% |
| 2017-12-31 | $249.70 Million | $23.78 Million | 0.095x | -65.95% |
| 2016-12-31 | $138.91 Million | $38.85 Million | 0.280x | +47.98% |
| 2015-12-31 | $75.93 Million | $14.35 Million | 0.189x | +36.59% |
| 2014-12-31 | $63.68 Million | $8.81 Million | 0.138x | -17.87% |
| 2013-12-31 | $66.83 Million | $11.26 Million | 0.168x | +105.34% |
| 2012-12-31 | $70.00 Million | $5.74 Million | 0.082x | +27.22% |
| 2011-12-31 | $78.00 Million | $5.03 Million | 0.064x | -16.03% |
| 2010-12-31 | $134.93 Million | $10.36 Million | 0.077x | +45.11% |
| 2009-12-31 | $149.35 Million | $7.90 Million | 0.053x | -22.93% |
| 2008-12-31 | $150.12 Million | $10.31 Million | 0.069x | +676.27% |
| 2007-12-31 | $-26.87 Million | $-237.64K | 0.009x | -93.97% |
| 2006-12-31 | $-19.86 Million | $-2.91 Million | 0.147x | -- |
About Heartbeam Inc
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection … Read more